About NeuroEM Therapeutics
NeuroEM Therapeutics is a private company based in Tampa, Florida. It has reported $2,306,539 raised in two offerings on Form D since June 2024. Its chief executive is Chuck Papageorgiou.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 9, 2025 | Apr 23, 2025 | $1,946,539of $6.4M target | 23 | $84,632 | Equity, OptionsRule 506(b) | Form D ↗ |
| May 31, 2024 | Jun 17, 2024 | $360,000of $500K target | 12 | $30,000 | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, two offerings | $2,306,539 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on NeuroEM Therapeutics's Form D filed Apr 23, 2025.
CP
Chuck Papageorgiou
Chief Executive Officer and director
ML
Mitch Larimore
Director
JG
Jonathan Gordon
Director